Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Washington, District of Columbia
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1347178
- Fiscal year ends
- December
- Filer status
- Accelerated filer
Financials 8 of 70
News 8 of 258
Prospectuses and Registrations 8 of 30
- S-8 Registration statement for an employee plan Jun 5, 2026
- S-3 Shelf registration statement Feb 12, 2026
- S-8 Registration statement for an employee plan Jun 5, 2025
- S-8 Registration statement for an employee plan May 21, 2024
- S-8 Registration statement for an employee plan Jun 8, 2023
- S-3/A Shelf registration statement, amended May 3, 2023
- S-3 Shelf registration statement Feb 9, 2023
- S-8 Registration statement for an employee plan Jun 17, 2022
Proxies 8 of 38
- DEFA14A Extra proxy material Apr 23, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2026
- DEFA14A Extra proxy material May 27, 2025
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEFA14A Extra proxy material May 13, 2024
- DEFA14A Extra proxy material May 9, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
Ownership 8 of 572
- SCHEDULE 13G Large holder reported a passive stake Aug 19, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 13, 2026
- 4 Insider reported a trade Jun 8, 2026
- 4 Insider reported a trade Jun 8, 2026
- 4 Insider reported a trade Jun 8, 2026
- 4 Insider reported a trade Jun 8, 2026
- 4 Insider reported a trade Jun 8, 2026
- 4 Insider reported a trade Jun 8, 2026
Other 8 of 33
- EFFECT Notice that a registration became effective May 5, 2026
- CORRESP Reply to SEC staff Apr 24, 2026
- ARS Annual report sent to shareholders Apr 23, 2026
- UPLOAD Comment letter from SEC staff Feb 18, 2026
- ARS Annual report sent to shareholders Apr 25, 2025
- 8-A12B/A Registration of a security for exchange listing, amended Aug 8, 2024
- 8-A12B/A Registration of a security for exchange listing, amended May 3, 2024
- ARS/A Annual report sent to shareholders, amended Apr 29, 2024
Everything here comes from Vanda Pharmaceuticals Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.